DR MABEL MAYORGA - MD Overview
Upcoming Projects (DR MABEL MAYORGA - MD)
-
Don’t see a project related to the keyword you care about? Create your own!
Executed Projects (DR MABEL MAYORGA - MD)
-
A third look: Digging into the phase 2 TITRATE Clinical trial data on Pfizer's GLP-1 agonist candidate danuglipron (PF-06882961) in patients with type 2 diabetes and obesity.
Ticker: PFE
Executed On: Jun 12, 2023 at 02:00 PM EDT -
A third look: Discussing the potential of Viking therapeutics dual GLP-1/GIP Receptor Agonist, VK2735, in development for the potential treatment of obesity and various metabolic disorders
Tickers: VKTX, LLY
Executed On: Apr 10, 2023 at 01:00 PM EDT
Upcoming & Overdue Catalysts (DR MABEL MAYORGA - MD)
-
Don’t see a catalyst related to the keyword you care about? Create your own!
Strategic Initiatives (DR MABEL MAYORGA - MD)
-
Don’t see a strategic initiative related to the keyword you care about? Create your own!
